Pharma-Bio Serv (PBSV) Non Operating Income (2010 - 2023)

Pharma-Bio Serv's Non Operating Income history runs 13 years deep, the most recent figure standing at $126985.0 for Q3 2023.

• Non Operating Income for Q3 2023 came in at $126985.0, up 336.55% year-over-year; the trailing twelve-month figure through Jul 2023 was $628228.0 (up 1426.66% YoY), and the FY2022 annual result was $13418.0, down 99.32% from the prior year.
• Non Operating Income came in at $126985.0 for Q3 2023 at Pharma-Bio Serv, down from $192616.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.0 million in Q3 2021 to a low of -$53683.0 in Q3 2022.
• A 5-year average of $165699.7 and a median of $48584.0 in 2020 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income sank 136.9% in 2020 and jumped 39988.62% in 2023, its largest moves.
• Over 5 years, Non Operating Income stood at $57436.0 in 2019, then slumped by 98.88% to $641.0 in 2020, then soared by 104.37% to $1310.0 in 2021, then surged by 4639.08% to $62082.0 in 2022, then surged by 104.54% to $126985.0 in 2023.
• The last three Non Operating Income figures came in at $126985.0 (Q3 2023), $192616.0 (Q2 2023), and $246545.0 (Q1 2023), per Business Quant data.